The CCLG Germ Cell Tumour National Advisory Panel – Evaluation of referrals over a two-year period
Clinical Oncology · 2026-09 · 57 · 104255
DOI: 10.1016/j.clon.2026.104255 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Oncology, 2026-09. Verfasst von S. Depani und 15 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Depani, S., Penn, A., Redkar, R., Lumb, B., Brougham, M., Bailey, S., Ajithkumar, T., Arul, S., Wilson, S., Hayden, J., Freeman, A., Long, A., Stark, D., Stoneham, S., Murray, M., & Nicholson, J. (2026). The CCLG Germ Cell Tumour National Advisory Panel – Evaluation of referrals over a two-year period. Clinical Oncology, 57, 104255. https://doi.org/10.1016/j.clon.2026.104255
Vancouver
Depani S, Penn A, Redkar R, Lumb B, Brougham M, Bailey S, et al. The CCLG Germ Cell Tumour National Advisory Panel – Evaluation of referrals over a two-year period. Clinical Oncology. 2026;57:104255. doi:10.1016/j.clon.2026.104255
BibTeX
@article{Depani2026,
author = {Depani, S. and Penn, A. and Redkar, R. and Lumb, B. and Brougham, M. and Bailey, S. and Ajithkumar, T. and Arul, S. and Wilson, S. and Hayden, J. and Freeman, A. and Long, A.-M. and Stark, D. and Stoneham, S. and Murray, M.J. and Nicholson, J.C.},
title = {The CCLG Germ Cell Tumour National Advisory Panel – Evaluation of referrals over a two-year period},
journal = {Clinical Oncology},
year = {2026},
volume = {57},
pages = {104255},
doi = {10.1016/j.clon.2026.104255}
}
EUVIMED